Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Quetiapine impurity 12, also known as 7-Hydroxy quetiapine S-oxide, is identified as a drug impurity of quetiapine. This compound is important for pharmacokinetic studies and quality control assessments of quetiapine formulations. Its presence in pharmaceutical preparations requires monitoring to ensure product safety and efficacy in clinical applications. -
Drug Impurity
Dexamethasone impurity 1 is a known impurity of the corticosteroid Dexamethasone, primarily involved in pharmaceutical quality control. This compound is utilized in research to assess the purity of Dexamethasone formulations and to understand the implications of impurities on drug efficacy and safety. It serves as an important analytical standard for ensuring the integrity of corticosteroid products. -
Drug Impurity
Nicotinamide impurity 4 is a recognized impurity of Nicotinamide, primarily serving as a reference standard in drug development. It is important for assessing the purity and quality of Nicotinamide formulations. Researchers often utilize this impurity to ensure compliance with regulatory requirements during the analytical evaluation and characterization of pharmaceutical compounds. -
Drug Impurity
Azilsartan impurity 18 is a by-product associated with the synthesis of Azilsartan, an angiotensin II receptor antagonist. This impurity can be utilized in analytical studies to assess the purity and quality of pharmaceutical formulations containing Azilsartan. It plays a critical role in ensuring compliance with regulatory standards and understanding the implications of impurities in drug efficacy and safety. -
Drug Impurity
O-Methyl Meloxicam is a structural impurity of Meloxicam, primarily identified as impurity 4. It serves as a useful reference standard for analytical chemistry, particularly in the assessment of drug quality and purity. This compound is relevant in pharmacokinetic studies and stability testing within pharmaceutical research, aiding in the comprehensive characterization of Meloxicam formulations. -
Drug Impurity
Ketoprofen impurity 10 is a known impurity associated with the nonsteroidal anti-inflammatory drug, Ketoprofen. This compound is used primarily in pharmaceutical research to assess the purity and quality of Ketoprofen formulations. Its presence may affect the drug's efficacy and safety profile, making it essential for method development and validation in drug analysis. -
Drug Impurity
Rosuvastatin impurity 36 is a specific impurity related to the statin drug Rosuvastatin, which targets HMG-CoA reductase. This compound is critical for characterizing the purity and quality of Rosuvastatin formulations in pharmaceutical research. It is utilized in studies focusing on drug formulation, stability testing, and impurity profiling to ensure compliance with regulatory standards. -
Drug Impurity
Acetazolamide impurity 4 is a known impurity associated with Acetazolamide, a carbonic anhydrase inhibitor. This compound serves as a critical reference standard for analytical applications in drug development and quality control. Its characterization is essential for ensuring the purity and efficacy of Acetazolamide formulations in pharmaceutical research. -
Drug Impurity
Thioridazine impurity 2 is a chemical impurity associated with the antipsychotic agent Thioridazine. It may serve as a valuable reference standard for analytical testing and quality control in pharmaceutical research. This compound is pertinent for studies focused on drug purity and the characterization of Thioridazine formulations. -
Drug Impurity
Apixaban impurity 3 is a chemical impurity associated with Apixaban, an anticoagulant that inhibits Factor Xa, playing a critical role in the coagulation cascade. This impurity is important for quality control and analytical studies in pharmaceutical research to ensure the safety and efficacy of Apixaban formulations. Researchers may utilize this compound for stability testing and impurity profiling as part of regulatory compliance in drug development. -
Drug Impurity
Glipizide impurity 9 is a known impurity associated with Glipizide, an antihyperglycemic agent used to manage diabetes mellitus. This compound is relevant for researchers focusing on the pharmacokinetics and safety profiles of Glipizide formulations. Its study is crucial for ensuring the quality and efficacy of pharmaceutical products in diabetes treatment. -
Drug Impurity
Trazodone impurity 13 is a known impurity associated with the antidepressant Trazodone. This compound serves as a crucial reference standard for assessing the purity and quality of Trazodone formulations. Its identification and quantification are essential in pharmaceutical development and quality control processes, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Mycophenolate impurity 1, also known as O-Desmethyl mycophenolate mofetil, serves as a drug impurity associated with Mycophenolate. This compound is essential for quality control and analytical applications in pharmaceutical development, particularly in assessing the purity of Mycophenolate formulations. Its presence can influence the pharmacokinetics and efficacy of Mycophenolate, making it a relevant focus for researchers investigating drug formulation and safety. -
Drug Impurity
Carvedilol impurity 2, or 6,7,8,9-Tetrahydro carvedilol, functions as a drug impurity associated with carvedilol synthesis. This compound may be utilized in pharmacological studies to assess the purity of carvedilol and investigate its pharmacokinetic properties. Understanding the presence and effects of this impurity can aid in refining drug formulation and ensuring optimal therapeutic efficacy. -
Drug Impurity
Ketoprofen impurity 11 is a chemical impurity associated with the analgesic and anti-inflammatory agent Ketoprofen. This impurity can play a critical role in pharmacological research, particularly in the development and quality control of pharmaceutical formulations. Its characterization and analysis are essential for ensuring the safety and effectiveness of Ketoprofen-derived products. -
Drug Impurity
Fenirofibrate impurity 3 is a structural byproduct of Fenirofibrate, a medication primarily used to treat lipid disorders. This impurity is critical for quality control and analytical studies in pharmaceutical research, ensuring the safety and efficacy of the drug. Additionally, it serves as a reference material in the characterization and analysis of Fenirofibrate formulations. -
Drug Impurity
Salbutamol impurity 2 hydrochloride is a known impurity of Salbutamol hydrochloride. This compound serves as an important reference standard for the identification and quantification of impurities in pharmaceutical formulations. It is primarily used in analytical chemistry and quality control processes within the pharmaceutical industry to ensure the safety and efficacy of Salbutamol-containing products. -
Drug Impurity
Duloxetine impurity 13 is a significant impurity associated with the pharmaceutical compound Duloxetine. This reagent is crucial for analytical and quality control studies to assess the purity of Duloxetine formulations. It is primarily utilized in the characterization and quantification of drug impurities within pharmaceutical research and development. -
Drug Impurity
Dabigatran impurity 10 is a chemical impurity associated with the anticoagulant drug Dabigatran. This substance is crucial for analytical and quality control studies in pharmaceutical research, particularly in the context of drug formulation and safety assessment. It plays a significant role in understanding the purity profiles and potential impacts of impurities in pharmacological applications. -
Drug Impurity
Famotidine impurity 7, also known as Famotidine disulfide, is a chemical impurity associated with Famotidine. It serves as a valuable reference standard for analytical characterization and quality control in pharmaceutical research. Its presence may affect the safety and efficacy profiles of formulations containing Famotidine, making it relevant for studies focused on drug metabolism and impurities. -
Drug Impurity
Tenofovir impurity 14 is a chemical impurity associated with the antiviral agent Tenofovir. This impurity can be utilized in the quality control and analytical testing of Tenofovir formulations. Its presence in drug preparations is critical for evaluating the purity and safety of pharmaceutical products, making it relevant for analytical chemistry and pharmaceutical research. -
Drug Impurity
Tramadol impurity 3 is a chemical impurity associated with Tramadol. It serves as an important reference standard for quality control and analytical purposes in pharmaceutical development. Researchers can utilize this impurity to assess the purity and stability of Tramadol formulations, ensuring compliance with regulatory standards. Analysis of such impurities helps in understanding potential effects on drug safety and efficacy. -
Drug Impurity
Ropinirole impurity 5 is a chemical impurity associated with Ropinirole, a dopamine agonist primarily targeting the D2 and D3 dopamine receptors. This impurity is important for analytical and quality control purposes in pharmaceutical research and development. Its identification and quantification are crucial for ensuring the purity and safety of Ropinirole formulations. -
Drug Impurity
Cinacalcet impurity 1 hydrochloride is a known impurity of the calcimimetic agent Cinacalcet, which primarily targets the calcium-sensing receptor. This compound is important for quality control and analytical studies in the development and regulatory assessment of Cinacalcet. It can also be used in research focused on drug metabolism and pharmacokinetics associated with calcimimetic therapies. -
Drug Impurity
Tacrolimus impurity 8, also known as delta23-FK-506, is a characterized impurity of the immunosuppressive agent Tacrolimus. This compound is primarily utilized for the assessment of drug purity and quality control in pharmaceutical development. Its presence can serve as a critical reference for analytical methods aimed at ensuring the safety and efficacy of Tacrolimus formulations. -
Drug Impurity
Carbamazepine impurity 8 is a structural impurity of the anticonvulsant drug carbamazepine, primarily identified during analytical studies. This compound can be utilized in drug development and regulatory compliance assessments to ensure the purity and quality of carbamazepine formulations. Its presence and effects contribute to the understanding of the drug's safety profile and therapeutic efficacy in neuropharmacological research. -
Drug Impurity
Roxithromycin impurity 7 is a known impurity associated with the antibiotic Roxithromycin. This compound is utilized primarily in analytical chemistry for the characterization and quality control of Roxithromycin formulations. Its presence is significant in ensuring the safety and efficacy of pharmaceutical products. Researchers may employ Roxithromycin impurity 7 in studies focused on drug metabolism, stability, and impurity profiling. -
Drug Impurity
Moxifloxacin impurity 5, also known as Moxifloxacin impurity D, is a known impurity associated with the antibiotic Moxifloxacin. This compound serves as a critical reference standard for analytical development and quality control in pharmaceutical research. Its characterization is essential for understanding the implications of drug impurities on pharmacokinetics and safety profiles, facilitating compliance with regulatory standards in drug development. -
Drug Impurity
Itraconazole impurity 4 is identified as a drug impurity associated with Itraconazole. As an impurity, it is crucial for analytical studies, including the assessment of drug purity and stability profiles. This compound supports research in pharmaceutical development by ensuring compliance with regulatory standards for drug quality and safety. -
Drug Impurity
Amoxicillin Impurity 2 is a known impurity of the antibiotic Amoxicillin, often analyzed in drug quality assessments. This compound serves as a reference standard for evaluating the purity and stability of Amoxicillin formulations. Its characterization aids in compliance with regulatory guidelines and ensures the safety and efficacy of pharmaceutical products. -
Drug Impurity
Rivaroxaban impurity 11 is a chemical impurity associated with the anticoagulant Rivaroxaban. This compound is crucial for analytical studies aimed at assessing the purity and quality of Rivaroxaban formulations. Its presence can significantly impact pharmacokinetics and safety profiles, making it essential for regulatory compliance and stability testing in pharmaceutical research. -
Drug Impurity
Nimesulide impurity 2 is a known impurity associated with the non-steroidal anti-inflammatory drug Nimesulide. This compound is important for analytical characterization and quality control in pharmaceutical research. It can aid in studying the stability and purity of Nimesulide formulations, contributing to the assessment of drug safety and efficacy. Researchers utilize this impurity to ensure compliance with regulatory standards in drug development. -
Drug Impurity
Donepezil impurity 22 is a known impurity associated with the cholinesterase inhibitor Donepezil. It serves as a valuable reference standard for the analysis and characterization of Donepezil formulations. This reagent is relevant for quality control and method validation in pharmaceutical research, ensuring the integrity and purity of therapeutic compounds. -
Drug Impurity
Bupropion impurity 6 is a byproduct of the synthesis of the antidepressant Bupropion. This chemical impurity can be used as a standard reference material in analytical chemistry to ensure the quality and consistency of pharmaceutical formulations. Its presence in drug formulations may affect pharmacological properties and assessment of quality control measures in drug development processes. -
Drug Impurity
Aripiprazole impurity 15 is a known impurity associated with the antipsychotic agent Aripiprazole. This compound is used primarily in the analysis of pharmaceutical formulations and serves as a reference standard for quality control and regulatory compliance. Its characterization aids in the assessment of drug purity and the development of analytical methodologies in pharmaceutical research. -
Drug Impurity
Cabozantinib impurity 1 is an impurity associated with the tyrosine kinase inhibitor Cabozantinib, which primarily targets MET, VEGFR, and RET signaling pathways. This compound is used in research to assess the purity and quality of Cabozantinib formulations, ensuring compliance with pharmaceutical standards. Its characterization is essential for the development and manufacturing of Cabozantinib and the evaluation of its pharmacological properties. -
Drug Impurity
Irbesartan impurity 6 hydrochloride is a chemical impurity associated with the synthesis of Irbesartan hydrochloride. This reagent serves as an important tool for quality control and impurity profiling in pharmaceutical research. Its characterization is essential for ensuring drug safety and efficacy in compliance with regulatory standards. -
Drug Impurity
Linagliptin impurity 47 is a known impurity associated with Linagliptin, a DPP-4 inhibitor used in the treatment of type 2 diabetes. This compound is critical for assessing the purity and quality of Linagliptin formulations. It plays a significant role in pharmacokinetic studies and drug development, ensuring compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Buspirone impurity 2 is identified as 5-Chloro buspirone, a known impurity associated with the pharmacological compound Buspirone. This chemical is utilized primarily in drug development and quality control processes to ensure the purity of Buspirone formulations. Its presence and characterization are critical for regulatory compliance and effectiveness in therapeutic applications, particularly those related to anxiolytic activity. -
Drug Impurity
Amiodarone impurity 2 is a known impurity of the antiarrhythmic agent Amiodarone, primarily acting as a drug impurity. Its identification and analysis are crucial for ensuring the safety and efficacy of Amiodarone formulations. This compound can be utilized in research applications aimed at quality control and regulatory compliance in pharmaceutical development. -
Drug Impurity
Azilsartan impurity 22, also known as Azilsartan impurity A, is a chemical impurity associated with the antihypertensive agent Azilsartan. This compound is primarily used for quality control and analytical purposes in pharmaceutical research. Studying this impurity is essential for ensuring the safety, efficacy, and compliance of Azilsartan in therapeutic applications. -
Drug Impurity
Paliperidone impurity 10, also known as Paliperidone E-oxime, serves as a significant impurity associated with the antipsychotic compound Paliperidone. This chemical is essential for quality control in pharmaceutical formulations, enabling researchers to assess the purity and stability of Paliperidone-related products. Its characterization contributes to the understanding of the compound's behavior and safety profile in drug development. -
Drug Impurity
Candesartan impurity 8 is characterized as a synthetic impurity associated with Candesartan. It serves as a critical reference standard for quality control and validation in pharmaceutical research. This compound is essential for assessing the purity and stability of Candesartan formulations, contributing to regulatory compliance and safety assessments in drug development. -
Drug Impurity
Aripiprazole impurity 8 is a characterized impurity associated with the antipsychotic agent Aripiprazole. This compound serves as a valuable reference standard for the analysis of drug purity and quality control in pharmaceutical research. Its identification is crucial for ensuring the safety and efficacy of Aripiprazole formulations. -
Drug Impurity
Solifenacin impurity 4 ((1R,3S)-Solifenacin) is identified as an impurity associated with the pharmaceutical compound Solifenacin. This reagent is crucial for analytical research and quality control in the characterization of drug formulations. Its study may assist in understanding the chemical profile of Solifenacin and its potential impacts on pharmacological activity and safety. -
Drug Impurity
Tacrolimus impurity 7 is a chemical impurity derived from Tacrolimus, an immunosuppressant used in organ transplantation. This impurity is essential for analytical and quality control studies, enabling researchers to assess the purity and stability of Tacrolimus formulations. Its characterization contributes to the understanding of drug metabolism and safety profiles in pharmaceutical development. -
Drug Impurity
Famotidine impurity 12 is a chemical impurity associated with famotidine, a selective H2 receptor antagonist. This reagent serves as a reference standard for analytical testing and quality control in pharmaceutical formulations. It is utilized in research to assess the stability, efficacy, and safety profiles of famotidine-containing products. -
Drug Impurity
Ramipril impurity 9 is a chemical impurity associated with the ACE inhibitor ramipril. It is utilized primarily for quality control and analytical purposes during drug development and formulation. Researchers can leverage this impurity to assess the purity, stability, and overall quality of ramipril as part of pharmaceutical research. -
Drug Impurity
Prasugrel impurity 11 is a known impurity associated with Prasugrel, a potent antiplatelet agent targeting the P2Y12 ADP receptor. This compound serves as an important reference standard in the quality control and analytical assessment of Prasugrel formulations. It is essential for researchers involved in drug development and regulatory compliance to ensure the safety and efficacy of their pharmaceutical products. -
Drug Impurity
Azithromycin impurity 9, also known as N',N'-Di(desmethyl)azithromycin, serves as a chemical impurity associated with the antibiotic Azithromycin. This compound is crucial for ensuring the quality and purity of pharmaceutical formulations and can be utilized in analytical research to evaluate the stability and degradation of azithromycin in various conditions. Its characterization is important for compliance with regulatory standards in drug development and quality control processes.
